Expression of organic anion transporter 1 or 3 in human kidney proximal tubule cells reduces cisplatin sensitivity
TTG Nieskens, JGP Peters, D Dabaghie, D Korte… - Drug Metabolism and …, 2018 - ASPET
Cisplatin is a cytostatic drug used for treatment of solid organ tumors. The main adverse
effect is organic cation transporter 2 (OCT2)–mediated nephrotoxicity, observed in 30% of …
effect is organic cation transporter 2 (OCT2)–mediated nephrotoxicity, observed in 30% of …
Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity
TTG Nieskens, JGP Peters… - … : the biological fate …, 2018 - pubmed.ncbi.nlm.nih.gov
Cisplatin is a cytostatic drug used for treatment of solid organ tumors. The main adverse
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …
[PDF][PDF] Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity s
TTG Nieskens, JGP Peters, D Dabaghie… - DRUG METABOLISM …, 2018 - core.ac.uk
The main adverse effect is organic cation transporter 2 (OCT2)–mediated nephrotoxicity,
observed in 30% of patients. The contribution of other renal drug transporters is elusive …
observed in 30% of patients. The contribution of other renal drug transporters is elusive …
Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity.
TTG Nieskens, JGP Peters, D Dabaghie… - Drug Metabolism and …, 2018 - europepmc.org
Cisplatin is a cytostatic drug used for treatment of solid organ tumors. The main adverse
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …
[PDF][PDF] Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity
TTG Nieskens, JGP Peters, D Dabaghie, D Korte… - 2018 - repository.ubn.ru.nl
Cisplatin is a cytostatic drug used for treatment of solid organ tumors. The main adverse
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …
Expression of organic anion transporter 1 or 3 in human kidney proximal tubule cells reduces cisplatin sensitivity
TTG Nieskens, JGP Peters, D Dabaghie, D Korte… - Drug Metabolism and …, 2018 - ASPET
Cisplatin is a cytostatic drug used for treatment of solid organ tumors. The main adverse
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …
effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of …